Founded
31 Dec 2007

Address

Kolltan Pharmaceuticals Inc
300 George Street
Suite 530
New Haven, CT 06511
United States

Open Map

Kolltan Pharmaceuticals Inc
300 George Street
Suite 530
New Haven, CT 06511
United States

Open Map

Kolltan Pharmaceuticals Inc
300 George Street
Suite 530
New Haven, CT 06511
United States

Open Map

Kolltan Pharmaceuticals Inc
300 George Street
Suite 530
New Haven, CT 06511
United States

Open Map

Kolltan Pharmaceuticals Inc
300 George Street
Suite 530
New Haven, CT 06511
United States

Open Map Open Map Open Map

Phone
203-773-3000
203-773-3000
203-773-3000
203-773-3000
203-773-3000
203-773-3000
203-773-3000
Website
http://www.kolltan.com
Industry
2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

VCID: 349622
Profile

Corporate information


Registration country
United States
Investment activity status
Active investor

Company type

Oncology therapeutics company, develops monoclonal antibody drugs targeting receptor tyrosine kinases.

Funding rounds

Series A

(1 Oct 2009)

Profile Country Notes
HBM BioVentures AG Switzerland

N/A


Profile Country Notes
Hatteras Venture Partners II United States

Series B


Profile Country Notes
Celtic Therapeutics Management LLLP United States

N/A


Profile Country Notes
Elm Street Ventures United States

Current and past shareholders

Investor Contacts Round
Celtic Therapeutics Management LLLP
 +1 (212) 616-4061
 Series B
Elm Street Ventures
 +1 (203) 401-4201
 N/A
Hatteras Venture Partners II logo Hatteras Venture Partners II
 +1 (919) 484-0730
 N/A
HBM BioVentures AG logo HBM BioVentures AG
 +41 (41) 768-1108
 Series A